Characteristics of Renal Blood Flow in AKI Patients in ICU and Its Clinical Significance
NCT ID: NCT06090773
Last Updated: 2024-02-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
96 participants
OBSERVATIONAL
2023-06-01
2023-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Application of Quantitative Ultrasonographic Analysis in Early Kidney Injury
NCT05662774
The Application of Contrast-enhanced Ultrasound in Acute Kidney Injury in ICU
NCT06341062
Relationship Between Renal Venous Return and Prognosis of Renal Function in Patients With AKI in ICU
NCT06159010
Diagnostic Value of Urinary Indices in Differentiating Pre-renal and Renal Acute Kidney Injury
NCT02376712
Bedside Renal Ultrasound Assessment in Patients With Acute Kidney Injury
NCT06156098
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acute kidney injury
Patients with acute injuries in ICU patients.
No interventions assigned to this group
Patients with non-acute kidney injury
ICU patients without acute injury patients.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking Union Medical College Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rongping Chen
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-PUMCH-A-218
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.